BIOSYM A/S: Financial statements 2024
CVR: 21774189
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
BIOSYM A/S (CVR 21774189) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 16,196,407 and a net result of DKK 3,810,817 compared with DKK 4,111,637 the year before. That is an increase of 5.6% compared with the year before. Equity in the 2024 report amounted to DKK 37,781,191. The solvency ratio was 64.9%. The company had 19 employees in the financial year.
- Gross Profit
- DKK 16,196,407
- Profit/Loss
- DKK 3,810,817
- Equity
- DKK 37,781,191
- Total Assets
- DKK 58,197,463
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 16.2 mio. | 3.8 mio. | 37.8 mio. | 19 |
| 2023 | - | 15.3 mio. | 4.1 mio. | 34 mio. | 18 |
| 2022 | - | 13 mio. | 2.1 mio. | 29.9 mio. | 18 |
| 2021 | - | 18.6 mio. | 7.1 mio. | 27.7 mio. | 18 |
| 2020 | - | 18 mio. | 6.7 mio. | 20.6 mio. | 19 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of November 28, 2024, Kati Marika Rajala has joined the board of directors of BIOSYM A/S.
As of November 28, 2024, Sami Oinas has left the board of directors of BIOSYM A/S.
BIOSYM A/S has published its annual report for 2023. Gross profit came to DKK 15,335,405, and the net result was DKK 4,111,637.
About BIOSYM A/S
BIOSYM A/S is a Danish company of the type Aktieselskab based in Ikast, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Sanne Biisgaard. The board consists of Kati Marika Rajala (chair), Elina Liisa Maarit Haavisto and Janne Vertanen. The company is owned by Oy Verman Ab. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 23,552,721 and a net result of DKK 8,530,373 compared with DKK 3,810,817 the year before. Equity in the 2025 report amounted to DKK 46,311,564.